Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops

dc.contributor.author	Sánchez Ávila, Ronald Mauricio
dc.contributor.author	Merayo Lloves, Jesús
dc.contributor.author	Riestra Ayora, Ana Cristina
dc.contributor.author	Fernández-Vega Cueto-Felgueroso, Luis
dc.contributor.author	Anitua, Eduardo
dc.contributor.author	Begoña, Leire
dc.contributor.author	Muruzabal, Francisco
dc.contributor.author	Orive, Gorka
dc.date.accessioned	2017-06-26T10:03:41Z
dc.date.available	2017-06-26T10:03:41Z
dc.date.issued	2018
dc.identifier.citation	International Ophthalmology, 38(3), p. 1193-1204 (2018); DOI: 10.1007/s10792-017-0582-7
dc.identifier.issn	0165-5701
dc.identifier.issn	1573-2630
dc.identifier.uri	http://hdl.handle.net/10651/42880
dc.description.sponsorship	This study received funding from the Ministry of Economy and Competitiveness of the Spanish Government, within the project denominated SURFEYE (reference RTC-2014-2375-1)	spa
dc.format.extent	1193-1204
dc.language.iso	eng	spa
dc.publisher	Springer Science+Business Media B.V.	spa
dc.relation.ispartof	International Ophthalmology, 38	spa
dc.rights	© Springer Science+Business Media B.V. 2017
dc.title	Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops	eng
dc.type	journal article	spa
dc.identifier.doi	10.1007/s10792-017-0582-7
dc.relation.projectID	MINECO/RTC-2014-2375-1	spa
dc.relation.publisherversion	http://dx.doi.org/10.1007/s10792-017-0582-7	spa

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.